We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Disease Modeling
Moving Beyond Animal Models with iPSC-based Models: Shifts and New Challenges
For decades, animal models have served as the foundation of biomedical research and drug development. However, growing ethical concerns, high costs, and limited Read more...Patient-derived Organoids for Cell Therapy Development: The Needs Behind the Innovation
Advances in human-relevant disease models have reshaped early-stage drug discovery, but the development of cell therapies demands even more sophisticated platforms Read more...
Recent Posts
- Moving Beyond Animal Models with iPSC-based Models: Shifts and New Challenges
- Patient-derived Organoids for Cell Therapy Development: The Needs Behind the Innovation
-
How Monoclonal Antibodies Have Transformed Breast Cancer Treatment, and Where is it Going Next -
Meet the Team: Interview with Brandon Pence – President and Chief Operating Officer -
Meet the Team: Interview with Robert Hodge – Senior Director, Corporate Planning
